Emvita 13 NDC 66343-100

NDC codes

FDA NDC Directory

Product NDC (as listed)66343-100Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66343-0100Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66343-100-60	66343010060	60 mL in 1 BOTTLE (66343-100-60)Marketed from Dec 23, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Emvita 13
Generic name (nonproprietary): anacard occ, bothrops, calc carb, graphites, thymus gland
Active ingredients: Anacardium occidentale fruit — 21 [hp_X]/60mLBothrops atrox venom — 800 [hp_C]/60mLOyster shell calcium carbonate, Crude — 16 [hp_M]/60mLGraphite — 18 [hp_M]/60mLBos taurus thymus — 21 [hp_X]/60mL
Dosage form: Liquid
Route: Oral
Labeler: RUBIMED AG
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Dec 23, 2022
Listing expires: Dec 31, 2026
Identifiers: Product ID 66343-100_2817453b-92b1-a7d3-e063-6394a90a8d59SPL ID 2817453b-92b1-a7d3-e063-6394a90a8d59SPL set ID 7f02d39c-e3e0-4a5d-b3af-043cafd4eff1UNII 4A10JR4E7E, K0Q6REZ9JC, 2E32821G6I, 4QQN74LH4O, 8XEJ88V2T8

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466343010060 followed by a unit qualifier and the quantity

Package 66343-0100-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 29, 2024.

Indications (excerpt from the label)

Uses: (†) Homeopathic remedy for general well being: feeling restrained.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)